ArticleEye (London, England)2025
Dry eye disease treatment following refractive surgery among young patients: a population-based study.
Article in Eye (London, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Preoperative and postoperative risk factors for persistent dry eye after corneal refractive surgery in ultra-high myopia: a retrospective cohort study.American journal of translational research · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesTo evaluate the demand for dry eye disease (DED) lubricating eye drop treatment following refractive surgery among young patients.
methodsThis study involved Israeli adolescents and young adults aged 16-20 years who underwent systematic medical evaluations from 2011 to 2019. Refractive surgery status was determined based on medical records. Lubricating eye drop usage was monitored through computerized dispensation data over a three-year period. Regression models, stratified by sex and adjusted for sociodemographic variables, were used.
resultsAmong 591,919 individuals (57.4% male, mean age 17.2 years), 4571 (0.8%) underwent refractive surgery. Lubricating eye drop usage was observed in 1.4% of men and 2.3% of women, with higher proportions in the refractive surgery group (4.0% vs. 1.4% and 9.5% vs. 2.3% for men and women, respectively; p < 0.001). Adjusted odds ratios (aORs) for increased DED treatment durations in men were 2.34 (95% CI 1.94-2.83) for ≤3 months, 5.22 (95% CI 3.43-7.94) for 3 to 12 months, and 5.79 (95% CI 3.69-9.09) for over 12 months. For women, aORs were 3.68 (95% CI 2.50-5.41) for ≤3 months, 6.06 (95% CI 2.50-14.73) for 3-12 months, and 11.57 (95% CI 4.74-28.25) for over 12 months.
conclusionsYoung patients after refractive surgery are significantly more likely to require DED lubricating eye drops for over a year following the procedure.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.